Is there any predictor for relapse after treatment withdrawal in autoimmune hepatitis patients in the real life?

BACKGROUNDS AND AIMS: In autoimmune hepatitis, there are uncertainties about whether to discontinue the treatment, when the treatment should be discontinued, and the risks of relapse in the cases where remission is achieved with immunosuppressive therapy. In this study, patients with AIH, whose immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Çavuş, Bilger, Akyuz, Filiz, İliaz, Raim, Atasoy, Alp, Akyuz, Umit, Demir, Kadir, Besisik, Fatih, Kaymakoglu, Sabahattin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855400/
https://www.ncbi.nlm.nih.gov/pubmed/35171719
http://dx.doi.org/10.1177/03946320221077860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855400/
https://www.ncbi.nlm.nih.gov/pubmed/35171719
http://dx.doi.org/10.1177/03946320221077860

Ejemplares similares